PRCT vs. NVO
Compare and contrast key facts about PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRCT or NVO.
Correlation
The correlation between PRCT and NVO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PRCT vs. NVO - Performance Comparison
Key characteristics
PRCT:
0.25
NVO:
-1.09
PRCT:
1.02
NVO:
-1.50
PRCT:
1.11
NVO:
0.80
PRCT:
0.37
NVO:
-0.85
PRCT:
1.03
NVO:
-1.76
PRCT:
15.54%
NVO:
23.57%
PRCT:
64.70%
NVO:
38.17%
PRCT:
-63.51%
NVO:
-71.32%
PRCT:
-43.66%
NVO:
-48.15%
Fundamentals
PRCT:
$3.07B
NVO:
$340.08B
PRCT:
-$1.75
NVO:
$3.31
PRCT:
$224.50M
NVO:
$290.40B
PRCT:
$135.83M
NVO:
$245.88B
PRCT:
-$81.99M
NVO:
$148.56B
Returns By Period
In the year-to-date period, PRCT achieves a -30.41% return, which is significantly lower than NVO's -11.78% return.
PRCT
-30.41%
-15.11%
-30.30%
11.66%
N/A
N/A
NVO
-11.78%
-9.37%
-44.47%
-42.52%
23.80%
14.30%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PRCT vs. NVO — Risk-Adjusted Performance Rank
PRCT
NVO
PRCT vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRCT vs. NVO - Dividend Comparison
PRCT has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.90%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRCT PROCEPT BioRobotics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.90% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
PRCT vs. NVO - Drawdown Comparison
The maximum PRCT drawdown since its inception was -63.51%, smaller than the maximum NVO drawdown of -71.32%. Use the drawdown chart below to compare losses from any high point for PRCT and NVO. For additional features, visit the drawdowns tool.
Volatility
PRCT vs. NVO - Volatility Comparison
PROCEPT BioRobotics Corporation (PRCT) has a higher volatility of 18.54% compared to Novo Nordisk A/S (NVO) at 15.85%. This indicates that PRCT's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRCT vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities